These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2252771)

  • 1. Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis.
    Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
    ASAIO Trans; 1990; 36(3):M637-9. PubMed ID: 2252771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis.
    Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
    Artif Organs; 1994 Dec; 18(12):880-7. PubMed ID: 7887824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis.
    Kjellstrand P; Jacobson SH; Skröder R; Holmquist B; Boberg U; Lins LE; Okmark P; Kjellstrand CM
    ASAIO Trans; 1990; 36(3):M314-6. PubMed ID: 2252687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
    Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
    Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysis.
    Akizawa T; Kino K; Kinugasa E; Koshikawa S; Ikada Y; Kishida A; Hatanaka Y; Imamura K
    ASAIO Trans; 1990; 36(3):M640-2. PubMed ID: 2252772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
    Akizawa T; Kinugasa E; Koshikawa S
    ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure: role of dialysis membrane biocompatibility.
    Pascual M; Swinford RD; Tolkoff-Rubin N
    Annu Rev Med; 1997; 48():467-76. PubMed ID: 9046977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
    Clark WR; Hamburger RJ; Lysaght MJ
    Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility.
    Strasser T; Schiffl H
    Klin Wochenschr; 1991 Oct; 69(17):808-12. PubMed ID: 1662325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of dialysis membrane upon protein catabolic rate.
    Lindsay RM; Spanner E; Heidenheim AP; Lindsay S; LeFebvre JM
    ASAIO Trans; 1991; 37(3):M134-5. PubMed ID: 1751080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of the dialysis membrane.
    Takemoto Y; Naganuma T; Yoshimura R
    Contrib Nephrol; 2011; 168():139-145. PubMed ID: 20938134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-related bioincompatibility of hemodialysis: inhibition of oxidative metabolism, degranulation reaction, enzyme release and leukocyte sequestration in the lung.
    Kolb G; Fischer W; Müller T; Höffken H; Joseph K; Lange H; Havemann K
    Int J Artif Organs; 1989 May; 12(5):294-8. PubMed ID: 2737768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.